Artivion, Inc.
AORT
Marshall S. Stanton
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Marshall S. Stanton
Artivion, Inc. reported in an 8-K filed August 11, 2025 that Marshall S. Stanton retired as Senior Vice President, Clinical Research and Chief Medical Officer, effective March 31, 2026. The proxy statement of Artivion, Inc. reports total compensation of $1,660,393 for Marshall S. Stanton in fiscal 2025, including a base salary of $443,929. Disclosed compensation is on record for 5 fiscal years.
“On August 6, 2025, Marshall S. Stanton, M.D., the Company's Senior Vice President, Clinical Research and Chief Medical Officer, notified the Company of his decision to retire, effective March 31, 2026 (the "Retirement Date"), from the position of Senior Vice President, Clinical Research and Chief Medical Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Artivion, Inc. (AORT)
Proxy statement
Start not stated–2026-03-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Artivion, Inc. (AORT) | Senior Vice President, Clinical Research and Chief Medical Officer | $443,929 | $1,660,393 |
| 2024 | Artivion, Inc. (AORT) | Senior Vice President, Clinical Research and Chief Medical Officer | $409,593 | $1,293,613 |
| 2023 | Artivion, Inc. (AORT) | Senior Vice President, Clinical Research and Chief Medical Officer | $395,742 | $942,000 |
| 2022 | Artivion, Inc. (AORT) | Senior Vice President, Clinical Research and Chief Medical Officer | $384,216 | $1,609,031 |
| 2021 | Artivion, Inc. (AORT) | Senior Vice President, Clinical Research and Chief Medical Officer | $295,673 | $947,228 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.